BioSpace News Archive

InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM369, an anti-CC chemokine receptor 8 (CCR8) monoclonal antibody, developed by a joint venture between the two companies called Tiannuojiancheng Pharma, has been approved by the China’s National Medical Products Administration (NMPA).

Wilmington, Delaware, United States, Transparency Market Research Inc. - The demand within the global liposomes market is expected to rise on account of advancements in medical and pharmaceutical research.

By Product Segment, The Oligonucleotide-Based Drugs Segment Accounted For The Largest Share Of The Oligonucleotide Synthesis Market.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Product Lifecycle Management (PLM) is used for maximizing the revenue generation capabilities of pharma companies

Brii Biosciences Limited (“Brii Bio,” “we,” or the “Company”, stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced a corporate update and reported its interim results for the six months ended June 30, 2022.

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), announced that the first patient dosing in Australia for its proprietary PD-1/IL-2 bispecific antibody fusion protein (R&D code: IBI363) in Phase I clinical trial for the treatment of patients with advanced solid tumors or lymphomas.

AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced the closing of an A$18 million Series B financing round led by Morningside.

Wilmington, Delaware, United States, Transparency Market Research Inc. - Cancer profiling is an alternative to all traditional approaches to cancer treatment. It uses a focused personalized approach to a treatment that specifically targets an individual patient’s tumor.

Wilmington, Delaware, United States, Transparency Market Research Inc. - Colorectal cancer starts within the colon or the rectum.

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 8:45 a.m. ET.